Centiva Capital »

Viking Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.6M 68k 53.01
2022-09-30 $29k 11k 2.68

More positions owned by Centiva Capital

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Agnc Invt Corp Com reit (AGNC)
Apple Put Option (AAPL)
Barclays Bank Ipth Sr B S&p Call Option
Microsoft Corporation Put Option (MSFT)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Alphabet Cap Stk Cl C Call Option (GOOG)
Super Micro Computer Put Option (SMCI)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Centiva Capital

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
Susquehanna International
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Geode Capital Management
Viking Global Investors
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
International Assets Investment Management
Morgan Stanley
Millennium Management

View all funds holding Viking Therapeutics